Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Carvalho LM, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Cardoso JMO, Reis AB, Carneiro CM, Roatt BM. Carvalho LM, et al. Parasitology. 2022 Mar;149(3):371-379. doi: 10.1017/S0031182021001906. Epub 2021 Nov 2. Parasitology. 2022. PMID: 35264268 Free PMC article.
Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis.
Gusmão MR, Ostolin TLVDP, Carvalho LM, Costa AFP, Moreira GJL, Cardoso JMO, Aguiar-Soares RDO, Reis AB, de Brito RCF, Roatt BM. Gusmão MR, et al. Among authors: carvalho lm. Vaccine. 2022 Sep 2;40(37):5494-5503. doi: 10.1016/j.vaccine.2022.08.005. Epub 2022 Aug 10. Vaccine. 2022. PMID: 35963820 Free article.
Heterologous vaccine therapy associated with half course of Miltefosine promote activation of the proinflammatory response with control of splenic parasitism in a hamster model of visceral leishmaniasis.
Carvalho LM, Ferreira FC, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Reis AB, Cardoso JMO, Carneiro CM, Roatt BM. Carvalho LM, et al. Curr Res Immunol. 2021 Nov 5;2:194-201. doi: 10.1016/j.crimmu.2021.10.003. eCollection 2021. Curr Res Immunol. 2021. PMID: 35492387 Free PMC article.
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF, Vale DL, Dias DS, Lage DP, Mendonça DVC, Ramos FF, Carvalho LM, Carvalho AMRS, Steiner BT, Roque MC, Oliveira-da-Silva JA, Oliveira JS, Tavares GSV, Galvani NC, Martins VT, Chávez-Fumagalli MA, Roatt BM, Moreira RLF, Menezes-Souza D, Oliveira MC, Machado-de-Ávila RA, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: carvalho lm, carvalho amrs. Cytokine. 2020 May;129:155031. doi: 10.1016/j.cyto.2020.155031. Epub 2020 Feb 12. Cytokine. 2020. PMID: 32062145
A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.
Tavares GSV, Mendonça DVC, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Perin L, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Bandeira RS, Silva AM, Chávez-Fumagalli MA, Duarte MC, Menezes-Souza D, Alves RJ, Roatt BM, Coelho EAF. Tavares GSV, et al. Among authors: carvalho lm, carvalho amrs. Parasite. 2020;27:29. doi: 10.1051/parasite/2020027. Epub 2020 Apr 30. Parasite. 2020. PMID: 32351209 Free PMC article.
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
Ribeiro PAF, Dias DS, Lage DP, Mendonça DVC, Vale DL, Ramos FF, Carvalho LM, Carvalho AMRS, Steiner BT, Roque MC, Oliveira-da-Silva JA, Oliveira JS, Tavares GSV, Martins VT, Chávez-Fumagalli MA, Roatt BM, Moreira RLF, Menezes-Souza D, Duarte MC, Oliveira MC, Machado-de-Ávila RA, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: carvalho lm, carvalho amrs. Parasitol Res. 2020 Aug;119(8):2609-2622. doi: 10.1007/s00436-020-06752-x. Epub 2020 Jun 13. Parasitol Res. 2020. PMID: 32535734
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
Oliveira-da-Silva JA, Lage DP, Ramos FF, Machado AS, Tavares GSV, Mendonça DVC, Pereira IAG, Martins VT, Carvalho LM, Ludolf F, Santos TTO, Reis TAR, Oliveira CS, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Menezes-Souza D, Roatt BM, Teixeira AL, Coelho EAF. Oliveira-da-Silva JA, et al. Among authors: carvalho lm. Mol Immunol. 2020 Aug;124:161-171. doi: 10.1016/j.molimm.2020.06.010. Epub 2020 Jun 22. Mol Immunol. 2020. PMID: 32585510
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Pereira IAG, Mendonça DVC, Tavares GSV, Lage DP, Ramos FF, Oliveira-da-Silva JA, Antinarelli LMR, Machado AS, Carvalho LM, Carvalho AMRS, Salustiano IV, Reis TAR, Bandeira RS, Silva AM, Martins VT, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Duarte MC, Menezes-Souza D, Coimbra ES, Leite JPV, Coelho EAF, Gonçalves DU. Pereira IAG, et al. Among authors: carvalho lm, carvalho amrs. Parasite Immunol. 2020 Dec;42(12):e12784. doi: 10.1111/pim.12784. Epub 2020 Aug 30. Parasite Immunol. 2020. PMID: 32772379
340 results